Yaakov Kacher, Ph.D.
Affiliations: | 2009 | BCH Biological Chemistry | Weizmann Institute of Science, Rehovot, Israel |
Area:
Biochemistry, Cell Biology, PathologyGoogle:
"Yaakov Kacher"Mean distance: (not calculated yet)
Parents
Sign in to add mentorAnthony H. Futerman | grad student | 2009 | Weizmann Institute | |
(Cell biology of Gaucher disease:pathological mechanisms and therapy.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kacher Y, Futerman AH. (2009) Impaired IL-10 transcription and release in animal models of Gaucher disease macrophages. Blood Cells, Molecules & Diseases. 43: 134-7 |
Kacher Y, Brumshtein B, Boldin-Adamsky S, et al. (2008) Acid β-glucosidase: Insights from structural analysis and relevance to Gaucher disease therapy Biological Chemistry. 389: 1361-1369 |
Kacher Y, Golan A, Pewzner-Jung Y, et al. (2007) Changes in macrophage morphology in a Gaucher disease model are dependent on CTP:phosphocholine cytidylyltransferase alpha. Blood Cells, Molecules & Diseases. 39: 124-9 |
Kacher Y, Futerman AH. (2006) Genetic diseases of sphingolipid metabolism: pathological mechanisms and therapeutic options. Febs Letters. 580: 5510-7 |
Kacher Y, Futerman AH. (2006) Neuronal cell death in glycosphingolipidoses Sphingolipid Biology. 285-293 |
Raas-Rothschild A, Pankova-Kholmyansky I, Kacher Y, et al. (2004) Glycosphingolipidoses: beyond the enzymatic defect. Glycoconjugate Journal. 21: 295-304 |
Ginzburg L, Kacher Y, Futerman AH. (2004) The pathogenesis of glycosphingolipid storage disorders. Seminars in Cell & Developmental Biology. 15: 417-31 |